tiprankstipranks
Trending News
More News >
CytomX Therapeutics Inc (CTMX)
NASDAQ:CTMX
US Market

CytomX Therapeutics (CTMX) Ratios

Compare
926 Followers

CytomX Therapeutics Ratios

CTMX's free cash flow for Q4 2025 was $0.00. For the 2025 fiscal year, CTMX's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
3.64 3.09 1.25 1.17 1.55
Quick Ratio
3.64 3.09 1.25 1.17 1.55
Cash Ratio
0.83 0.27 0.44 0.11 1.27
Solvency Ratio
0.58 -0.39 0.28 <0.01 -0.28
Operating Cash Flow Ratio
-1.84 -1.62 -1.01 -0.36 -0.73
Short-Term Operating Cash Flow Coverage
0.00 -17.83 0.00 0.00 0.00
Net Current Asset Value
$ 98.35M$ 91.36M$ -13.68M$ -66.30M$ -109.54M
Leverage Ratios
Debt-to-Assets Ratio
0.04 0.03 0.08 0.07 0.07
Debt-to-Equity Ratio
0.05 0.04 -20.58 -0.29 -0.21
Debt-to-Capital Ratio
0.05 0.04 1.05 -0.42 -0.27
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.47 1.53 -264.33 -4.25 -3.04
Debt Service Coverage Ratio
0.00 -5.33 0.00 0.00 0.00
Interest Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
0.00 <0.01 0.00 0.00 0.00
Interest Debt Per Share
0.03 <0.01 0.11 0.19 0.27
Net Debt to EBITDA
-1.09 0.38 -1.07 0.74 1.78
Profitability Margins
Gross Profit Margin
100.00%0.00%100.00%100.00%100.00%
EBIT Margin
21.86%0.00%18.10%-6.41%-190.61%
EBITDA Margin
22.99%-29.35%19.38%-4.26%-186.02%
Operating Profit Margin
20.46%-29.35%18.10%-6.41%-190.61%
Pretax Profit Margin
24.87%-22.48%23.24%3.28%-186.82%
Net Profit Margin
24.66%-26.73%23.08%-0.56%-186.82%
Continuous Operations Profit Margin
24.66%-26.73%23.08%-0.56%-186.82%
Net Income Per EBT
99.13%118.91%99.30%-17.12%100.00%
EBT Per EBIT
121.58%76.60%128.40%-51.25%98.01%
Return on Assets (ROA)
17.70%-13.44%26.44%-0.28%-38.07%
Return on Equity (ROE)
44.49%-20.57%-6988.82%1.20%115.82%
Return on Capital Employed (ROCE)
19.83%-21.31%71.91%-14.13%-93.58%
Return on Invested Capital (ROIC)
18.76%-20.48%62.20%2.20%-90.18%
Return on Tangible Assets
17.87%-13.56%26.78%-0.28%-38.34%
Earnings Yield
2.52%-0.35%36.64%-0.50%-94.42%
Efficiency Ratios
Receivables Turnover
69.76 37.85 44.51 29.49 1.48
Payables Turnover
0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
17.39 16.21 13.02 6.26 2.53
Asset Turnover
0.72 0.50 1.15 0.50 0.20
Working Capital Turnover Ratio
0.97 1.28 5.69 1.82 0.34
Cash Conversion Cycle
5.23 9.64 8.20 12.38 247.07
Days of Sales Outstanding
5.23 9.64 8.20 12.38 247.07
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
0.00 0.00 0.00 0.00 0.00
Operating Cycle
5.23 9.64 8.20 12.38 247.07
Cash Flow Ratios
Operating Cash Flow Per Share
-0.46 -0.05 -1.02 -0.76 -1.69
Free Cash Flow Per Share
-0.46 -0.05 -1.02 -0.77 -1.71
CapEx Per Share
<0.01 <0.01 <0.01 0.01 0.03
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.01 1.02
Dividend Paid and CapEx Coverage Ratio
-23.46 -23.46 -278.16 -66.71 -63.67
Capital Expenditure Coverage Ratio
-343.58 -343.58 -278.16 -66.71 -63.67
Operating Cash Flow Coverage Ratio
-13.51 -17.83 -9.19 -4.01 -6.14
Operating Cash Flow to Sales Ratio
-0.67 -0.99 -0.62 -0.55 -2.08
Free Cash Flow Yield
-6.63%-1.29%-99.50%-49.71%-106.98%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
39.75 -288.47 2.73 -201.06 -1.06
Price-to-Sales (P/S) Ratio
10.06 77.11 0.63 1.13 1.98
Price-to-Book (P/B) Ratio
10.37 59.35 -190.73 -2.41 -1.23
Price-to-Free Cash Flow (P/FCF) Ratio
-15.09 -77.51 -1.00 -2.01 -0.93
Price-to-Operating Cash Flow Ratio
-14.74 -77.74 -1.01 -2.04 -0.95
Price-to-Earnings Growth (PEG) Ratio
-1.44 2.07 >-0.01 2.02 -0.06
Price-to-Fair Value
10.37 59.35 -190.73 -2.41 -1.23
Enterprise Value Multiple
42.69 -262.37 2.18 -25.81 0.71
Enterprise Value
1.12B 5.87B 58.31M 111.21M -70.41M
EV to EBITDA
42.69 -262.37 2.18 -25.81 0.71
EV to Sales
9.81 77.00 0.42 1.10 -1.32
EV to Free Cash Flow
-14.71 -77.40 -0.67 -1.96 0.63
EV to Operating Cash Flow
-14.75 -77.63 -0.68 -1.98 0.64
Tangible Book Value Per Share
0.64 0.07 -0.02 -0.67 -1.33
Shareholders’ Equity Per Share
0.65 0.07 >-0.01 -0.64 -1.30
Tax and Other Ratios
Effective Tax Rate
<0.01 -0.01 <0.01 1.17 0.00
Revenue Per Share
0.69 0.06 1.64 1.37 0.81
Net Income Per Share
0.17 -0.01 0.38 >-0.01 -1.51
Tax Burden
0.99 1.19 0.99 -0.17 1.00
Interest Burden
1.14 0.00 1.28 -0.51 0.98
Research & Development to Revenue
0.55 0.90 0.60 0.77 2.10
SG&A to Revenue
0.25 0.39 0.22 0.30 0.81
Stock-Based Compensation to Revenue
0.06 0.08 0.06 0.08 0.00
Income Quality
4.35 3.71 -2.71 98.48 1.12
Currency in USD